急性重症心肌炎合并心衰应用主动脉内球囊反搏治疗的效果观察  

Observation on the effect of intra-aortic balloon counterpulsation for acute severe myocarditis complicated with heart failure

作　　者：王彦雯 张艳芳 WANG Yan-wen;ZHANG Yan-fang(Department of Cardiology,People’s Hospital of Inner Mongolia Autonomous Region,Hohhot 010000,China)

机构地区：[1]内蒙古自治区人民医院心内科,010000

出　　处：《中国实用医药》2022年第5期31-33,共3页China Practical Medicine

摘　　要：目的 分析急性重症心肌炎合并心力衰竭(心衰)应用主动脉内球囊反搏治疗的临床效果。方法 56例急性重症心肌炎合并心力衰竭患者,以随机数字表法分为参照组和试验组,每组28例。参照组采用常规治疗,试验组在参照组基础上采用主动脉内球囊反搏治疗。比较两组治疗效果、死亡率及肾功能、心功能指标。结果 试验组血肌酐(119.52±57.92)μmol/L、肾小球滤过率(eGFR)(71.12±25.42)[ml/(min·1.73 m^(2))]、24 h尿量(1066.00±290.50)ml、左心室射血分数(LVEF)(45.63±1.73)%、左室舒张末期内径(LVEDD)(52.30±2.12)mm、收缩压(102.52±8.12)mm Hg(1 mm Hg=0.133 kPa)、平均动脉压(75.03±8.89)mm Hg、心率(76.68±9.11)次/min均优于参照组的(198.70±72.36)μmol/L、(39.76±16.03)[ml/(min·1.73 m^(2))]、(662.00±262.36)ml、(37.05±3.50)%、(59.33±4.52)mm、(96.50±5.36)mm Hg、(67.00±6.30)mm Hg、(94.36±9.36)次/min,差异具有统计学意义(P<0.05)。试验组临床治疗总有效率82.14%高于参照组的53.57%,差异具有统计学意义(P<0.05)。试验组死亡发生率为3.57%(1/28),低于参照组的32.14%(9/28),差异有统计学意义(P<0.05)。结论 对急性重症心肌炎合并心力衰竭患者应用主动脉内球囊反搏治疗,有利于改善心功能和肾功能,避免发生死亡情况,治疗效果显著,值得在临床大范围推广。Objective To analyze the clinical effect of intra-aortic balloon counterpulsation for acute severe myocarditis complicated with heart failure.Methods A total of 56 patients with acute severe myocarditis and heart failure were divided into reference group and experimental group by random numerical table,with28 cases in each group.The reference group was treated with conventional therapy,and the experimental group was treated with intra-aortic balloon counterpulsation on the basis of the reference group.The therapeutic effect,mortality rate,renal function and cardiac function indexes were compared between the two groups.Results In the experimental group,the serum creatinine was(119.52±57.92)μmol/L,the estimated glomerular filtration rate(eGFR)was(71.12±25.42)[ml/(min·1.73 m^(2))],the 24-h urine volume was(1066.00±290.50)ml,the left ventricular ejection fraction(LVEF)was(45.63±1.73)%,the left ventricular end-diastolic diameter was(LVEDD)(52.30±2.12)mm,the systolic blood pressure was(102.52±8.12)mm Hg(1 mm Hg=0.133 kPa),the mean arterial pressure was(75.03±8.89)mm Hg and the heart rate was(76.68±9.11)beats/min,which were better than(198.70±72.36)μmol/L,(39.76±16.03)[ml/(min·1.73 m^(2))],(662.00±262.36)ml,(37.05±3.50)%,(59.33±4.52)mm,(96.50±5.36)mm Hg,(67.00±6.30)mm Hg,(94.36±9.36)beats/min of the reference group,and the difference was statistically significant(P<0.05).The total effective rate of clinical treatment in the experimental group was 82.14%,which was higher than 53.57%in the reference group,and the difference was statistically significant(P<0.05).The mortality rate in the experimental group was 3.57%(1/28),which was lower than 32.14%(9/28)in the reference group,and the difference was statistically significant(P<0.05).Conclusion The implementation of intra-aortic balloon counterpulsation in the treatment of acute severe myocarditis and heart failure is beneficial to improve the cardiac and renal function of patients,avoid death,and has a significant therapeutic effect.It is worthy of clin

关 键 词：急性重症心肌炎 心力衰竭 主动脉内球囊反搏 

分 类 号：R541.6[医药卫生—心血管疾病] R542.21[医药卫生—内科学]